329 related articles for article (PubMed ID: 17596870)
21. Serum adiponectin in chronic hepatitis C and B.
Siagris D; Vafiadis G; Michalaki M; Lekkou A; Starakis I; Makri M; Margaritis V; Christofidou M; Tsamandas AC; Labropoulou-Karatza C
J Viral Hepat; 2007 Aug; 14(8):577-83. PubMed ID: 17650292
[TBL] [Abstract][Full Text] [Related]
22. Relation of serum insulin-like growth factor-1 (IGF-1) levels with hepatitis C virus infection and insulin resistance.
Helaly GF; Hussein NG; Refai W; Ibrahim M
Transl Res; 2011 Sep; 158(3):155-62. PubMed ID: 21867981
[TBL] [Abstract][Full Text] [Related]
23. Glucose intolerance and hypoadiponectinemia are already present in lean patients with chronic hepatitis C infected with genotype non-3 viruses.
Anty R; Gelsi E; Giudicelli J; Mariné-Barjoan E; Gual P; Benzaken S; Saint-Paul MC; Sadoul JL; Huet PM; Tran A
Eur J Gastroenterol Hepatol; 2007 Aug; 19(8):671-7. PubMed ID: 17625437
[TBL] [Abstract][Full Text] [Related]
24. Insulin resistance is a cause of steatosis and fibrosis progression in chronic hepatitis C.
Fartoux L; Poujol-Robert A; Guéchot J; Wendum D; Poupon R; Serfaty L
Gut; 2005 Jul; 54(7):1003-8. PubMed ID: 15951550
[TBL] [Abstract][Full Text] [Related]
25. Elevated serum α-fetoprotein levels in patients with chronic hepatitis C virus genotype 4: not the end of the story.
Abdel-Razik A; Mousa N; Abdel-Aziz M; Elhelaly R; Elzehery R; Zalata K; Elkashef W; Fouda O; Awad M; Hafez M; Eldars W
Eur J Gastroenterol Hepatol; 2016 Mar; 28(3):313-22. PubMed ID: 26618566
[TBL] [Abstract][Full Text] [Related]
26. Insulin resistance in chronic hepatitis B virus infection.
Kumar M; Choudhury A; Manglik N; Hissar S; Rastogi A; Sakhuja P; Sarin SK
Am J Gastroenterol; 2009 Jan; 104(1):76-82. PubMed ID: 19098853
[TBL] [Abstract][Full Text] [Related]
27. Insulin resistance and diabetes increase fibrosis in the liver of patients with genotype 1 HCV infection.
Petta S; Cammà C; Di Marco V; Alessi N; Cabibi D; Caldarella R; Licata A; Massenti F; Tarantino G; Marchesini G; Craxì A
Am J Gastroenterol; 2008 May; 103(5):1136-44. PubMed ID: 18477344
[TBL] [Abstract][Full Text] [Related]
28. Serum adipokine levels predictive of liver injury in non-alcoholic fatty liver disease.
Lemoine M; Ratziu V; Kim M; Maachi M; Wendum D; Paye F; Bastard JP; Poupon R; Housset C; Capeau J; Serfaty L
Liver Int; 2009 Oct; 29(9):1431-8. PubMed ID: 19422483
[TBL] [Abstract][Full Text] [Related]
29. Leptin has no role in determining severity of steatosis and fibrosis in patients with chronic hepatitis C.
Giannini E; Ceppa P; Botta F; Mastracci L; Romagnoli P; Comino I; Pasini A; Risso D; Lantieri PB; Icardi G; Barreca T; Testa R
Am J Gastroenterol; 2000 Nov; 95(11):3211-7. PubMed ID: 11095344
[TBL] [Abstract][Full Text] [Related]
30. Serum levels of adipokines in patients with chronic HCV infection: relationship with steatosis and fibrosis.
Tiftikci A; Atug O; Yilmaz Y; Eren F; Ozdemir FT; Yapali S; Ozdogan O; Celikel CA; Imeryuz N; Tozun N
Arch Med Res; 2009 May; 40(4):294-8. PubMed ID: 19608019
[TBL] [Abstract][Full Text] [Related]
31. Adiponectin: a new independent predictor of liver steatosis and response to IFN-alpha treatment in chronic hepatitis C.
Zografos TA; Liaskos C; Rigopoulou EI; Togousidis E; Makaritsis K; Germenis A; Dalekos GN
Am J Gastroenterol; 2008 Mar; 103(3):605-14. PubMed ID: 18190648
[TBL] [Abstract][Full Text] [Related]
32. [Correlations between adipocytokines and insulin resistance in women with polycystic ovary syndrome].
Li X; Li X; Huang HY; Ma D; Zhu MW; Lin JF
Zhonghua Yi Xue Za Zhi; 2009 Oct; 89(37):2607-10. PubMed ID: 20137676
[TBL] [Abstract][Full Text] [Related]
33. Association of lipid profiles with hepatitis C viral load in chronic hepatitis C patients with genotype 1 or 2 infection.
Hsu CS; Liu CH; Liu CJ; Wang CC; Chen CL; Lai MY; Chen PJ; Chen DS; Kao JH
Am J Gastroenterol; 2009 Mar; 104(3):598-604. PubMed ID: 19262519
[TBL] [Abstract][Full Text] [Related]
34. Beyond insulin resistance in NASH: TNF-alpha or adiponectin?
Hui JM; Hodge A; Farrell GC; Kench JG; Kriketos A; George J
Hepatology; 2004 Jul; 40(1):46-54. PubMed ID: 15239085
[TBL] [Abstract][Full Text] [Related]
35. Fibrosis in genotype 3 chronic hepatitis C and nonalcoholic fatty liver disease: Role of insulin resistance and hepatic steatosis.
Bugianesi E; Marchesini G; Gentilcore E; Cua IH; Vanni E; Rizzetto M; George J
Hepatology; 2006 Dec; 44(6):1648-55. PubMed ID: 17133473
[TBL] [Abstract][Full Text] [Related]
36. Insulin resistance, serum leptin, and adiponectin levels and outcomes of viral hepatitis C cirrhosis.
Nkontchou G; Bastard JP; Ziol M; Aout M; Cosson E; Ganne-Carrie N; Grando-Lemaire V; Roulot D; Capeau J; Trinchet JC; Vicaut E; Beaugrand M
J Hepatol; 2010 Nov; 53(5):827-33. PubMed ID: 20728234
[TBL] [Abstract][Full Text] [Related]
37. Elevated serum tumor necrosis factor alpha and ferritin may contribute to the insulin resistance found in HCV positive Egyptian patients.
Elsammak M; Refai W; Elsawaf A; Abdel-Fattah I; Abd Elatti E; Ghazal A
Curr Med Res Opin; 2005 Apr; 21(4):527-34. PubMed ID: 15899101
[TBL] [Abstract][Full Text] [Related]
38. Interplay between oxidative stress and hepatic steatosis in the progression of chronic hepatitis C.
Vidali M; Tripodi MF; Ivaldi A; Zampino R; Occhino G; Restivo L; Sutti S; Marrone A; Ruggiero G; Albano E; Adinolfi LE
J Hepatol; 2008 Mar; 48(3):399-406. PubMed ID: 18164507
[TBL] [Abstract][Full Text] [Related]
39. Insulin resistance is associated with progression to hepatic fibrosis in a cohort of HIV/hepatitis C virus-coinfected patients.
Hull MW; Rollet K; Moodie EE; Walmsley S; Cox J; Potter M; Cooper C; Pick N; Saeed S; Klein MB;
AIDS; 2012 Sep; 26(14):1789-94. PubMed ID: 22739388
[TBL] [Abstract][Full Text] [Related]
40. Association between IL28B polymorphism, TNFα and biomarkers of insulin resistance in chronic hepatitis C-related insulin resistance.
Lemoine M; Chevaliez S; Bastard JP; Fartoux L; Chazouillères O; Capeau J; Pawlotsky JM; Serfaty L
J Viral Hepat; 2015 Nov; 22(11):890-6. PubMed ID: 25818002
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]